1
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency
Condition(s):X-Linked Combined Immunodeficiency DiseasesLast Updated:December 4, 2019Recruiting
AREA[OverallStatus] X-linked Severe Combined Immunodeficiency, Open or Pending: 8 Clinical Trials
Include Studies Not Open or Pending
2
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
Condition(s):X-Linked Severe Combined Immune Deficiency (XSCID)Last Updated:March 1, 2021Recruiting
3
Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Condition(s):Severe Combined Immunodeficiency, X-LinkedLast Updated:February 11, 2021Recruiting
4
Gene Therapy for X Linked Severe Combined Immunodeficiency
Condition(s):Gene TherapyLast Updated:March 27, 2020Recruiting
5
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Condition(s):Severe Combined Immunodeficiency Disease, X-linkedLast Updated:December 21, 2020Recruiting
6
Gene Transfer for SCID-X1 Using a Self-inactivating Lentiviral Vector （TYF-IL-2Rg）
Condition(s):SCID, X LinkedLast Updated:September 19, 2019Recruiting
7
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Condition(s):Severe Combined Immunodeficiency, X Linked; Gene TherapyLast Updated:January 7, 2021Recruiting
8
Evaluation of Patients With Immune Function Abnormalities
Condition(s):Chronic Granulomatous Disease (CGD); X-Linked Severe Combined Immune Deficiency (XSCID); Leukocyte Adhesion Deficiency 1 (LAD); Graft Versus Host Disease (cGvHD)Last Updated:February 26, 2021Recruiting